Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Operating expenses
General and administrative	$ 3,514,547	$ 2,123,834	$ 8,783,619	$ 10,864,696
Research and development	2,055,656	1,219,339	6,134,421	2,295,826
Depreciation and amortization	86,646	173,696	241,413	484,355
Total operating expenses	5,656,849	3,516,869	15,159,453	13,644,877
Loss from operations	(5,656,849)	(3,516,869)	(15,159,453)	(13,644,877)
Other income (expense)
Inducement expense				(298,714)
Change in fair value of warrant liabilities	1,599,623	804,833	3,845,514	7,077,376
Change in fair value of investment option liability	1,809,622		1,809,622
Change in fair value of derivative liability	(231,000)		(284,000)
Interest expense	(308)	(370)	(5,114)	(5,191)
Total other income	3,177,937	804,463	5,366,022	6,773,471
Net loss	(2,478,912)	(2,712,406)	(9,793,431)	(6,871,406)
Less preferred dividends attributable to non-controlling interest	12,603		20,411
Less deemed dividends attributable to accretion of embedded derivative at redemption value	110,991		184,985
Net loss attributable to shareholders	(2,602,506)	(2,712,406)	(9,998,827)	(6,871,406)
Other comprehensive loss
Foreign currency translation	(417,390)	(6,510)	(609,695)	(4,036)
Comprehensive loss	$ (3,019,896)	$ (2,718,916)	$ (10,608,522)	$ (6,875,442)
Net loss per share - basic and diluted	$ (1.46)	$ (5.91)	$ (8.11)	$ (16.64)
Weighted average shares outstanding, basic and diluted	1,787,235	459,289	1,232,936	413,063